Tonix Pharmaceuticals Holding Corp.
August 18, 2025 - by Joey Ramson
$TNXP has pulled back to its 50DMA today despite receiving approval from the US Food and Drug Administration (FDA) for Tonmya (cyclobenzaprine HCl sublingual tablets), which is used to treat fibromyalgia in adults.
